Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?

Journal of Surgical Oncology

Volumn 106, Issue 1, 2012, Pages 111-118

  Papalezova, Katia T ^a   Tyler, Douglas S ^b   Blazer III, Dan G ^b   Clary, Bryan M ^b   Czito, Brian G ^b   Hurwitz, Herbert I ^b   Uronis, Hope E ^b   Pappas, Theodore N ^b   Willett, Christopher G ^b   White, Rebekah R ^b  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cancer; Neoadjuvant; Pancreatic; Treatment

Indexed keywords

CAPECITABINE; FLUOROURACIL; GEMCITABINE;

ADULT; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREATIC HEAD ADENOCARCINOMA; PATIENT SELECTION; PREOPERATIVE RADIOTHERAPY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; TREATMENT OUTCOME; TUMOR VOLUME;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY, ADJUVANT; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MEDICAL RECORDS; MIDDLE AGED; NEOADJUVANT THERAPY; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84861964447     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23044     Document Type: Review

References (33)

1. Jemal A, Siegel R, Xu J, et al.: Cancer statistics. CA Cancer J Clin 2010;60:277-300.
2. Oettle H, Post S, Neuhaus P, et al.: Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial. JAMA 2007;297:267-277. (Pubitemid 46143304)
3. Ueno H, Kosuge T, Matsuyama Y, et al.: A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer. Br J Cancer 2009;101:908-915.
4. Smeenk HG, van Eijck CH, Hop WC, et al.: Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: Long-term results of EORTC trial 40891. Ann Surg 2007;246:734-740. (Pubitemid 350035648)
5. Klinkenbijl JH, Jeekel J, Sahmoud T, et al.: Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: Phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 1999;230:776-782; discussion 782-784.
6. Neoptolemos JP, Stocken DD, Friess H, et al.: A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004;350:1200-1210. (Pubitemid 38339364)
7. Regine WF, Winter KA, Abrams RA, et al.: Fluorouracil vs gemcitabine chemotherapy before, after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: A randomized controlled trial. JAMA 2008;299:1019-1026. (Pubitemid 351347058)
8. Palmer DH, Stocken DD, Hewitt H, et al.: A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: Gemcitabine alone versus gemcitabine combined with cisplatin. Ann Surg Oncol 2007;14:2088-2096. (Pubitemid 46988260)
9. Evans DB, Varadhachary GR, Crane CH, et al.: Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol 2008;26:3496-3502.
10. Heinrich S, Pestalozzi BC, Schafer M, et al.: Prospective phase II trial of neoadjuvant chemotherapy with gemcitabine and cisplatin for resectable adenocarcinoma of the pancreatic head. J Clin Oncol 2008;26:2526-2531.
11. Moutardier V, Turrini O, Huiart L, et al.: A reappraisal of preoperative chemoradiation for localized pancreatic head ductal adenocarcinoma in a 5-year single-institution experience. J Gastrointest Surg 2004;8:502-510. (Pubitemid 38561216)
12. Takai S, Satoi S, Yanagimoto H, et al.: Neoadjuvant chemoradiation in patients with potentially resectable pancreatic cancer. Pancreas 2008;36:e26-e32.
13. Talamonti MS, Small W, Jr., Mulcahy MF, et al.: A multiinstitutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma. Ann Surg Oncol 2006;13:150-158. (Pubitemid 43157408)
14. Varadhachary GR, Wolff RA, Crane CH, et al.: Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin Oncol 2008;26:3487-3495.
15. White RR, Kattan MW, Haney JC, et al.: Evaluation of preoperative therapy for pancreatic cancer using a prognostic nomogram. Ann Surg Oncol 2006;13:1485-1492. (Pubitemid 44749660)
16. Joensuu TK, Kiviluoto T, Karkkainen P, et al.: Phase I-II trial of twice-weekly gemcitabine and concomitant irradiation in patients undergoing pancreaticoduodenectomy with extended lymphadenectomy for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2004;60:444-452. (Pubitemid 39233463)
17. Bettini N, Moutardier V, Turrini O, et al.: Preoperative locoregional re-evaluation by endoscopic ultrasound in pancreatic ductal adenocarcinoma after neoadjuvant chemoradiation. Gastroenterol Clin Biol 2005;29:659-663. (Pubitemid 40957273)
18. Mornex F, Girard N, Scoazec JY, et al.: Feasibility of preoperative combined radiation therapy and chemotherapy with 5- fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trial. Int J Radiat Oncol Biol Phys 2006;65:1471-1478. (Pubitemid 44164277)
19. Turrini O, Viret F, Moureau-Zabotto L, et al.: Neoadjuvant 5 fluorouracil-cisplatin chemoradiation effect on survival in patients with resectable pancreatic head adenocarcinoma: A ten-year single institution experience. Oncology 2009;76:413-419.
20. Roh MS, Colangelo LH, O'Connell MJ, et al.: Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 2009;27:5124-5130.
21. Brunner TB, Grabenbauer GG, Meyer T, et al.: Primary resection versus neoadjuvant chemoradiation followed by resection for locally resectable or potentially resectable pancreatic carcinoma without distant metastasis. A multi-centre prospectively randomised phase II-study of the Interdisciplinary Working Group Gastrointestinal Tumours (AIO, ARO, and CAO). BMC Cancer 2007;7:41.
22. Gillen S, Schuster T, Meyer Zum Buschenfelde C, et al.: Preoperative/neoadjuvant therapy in pancreatic cancer: A systematic review and meta-analysis of response and resection percentages. PLoS Med 7:e1000267.
23. Charlson ME, Pompei P, Ales KL, et al.: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987;40:373-383. (Pubitemid 17055592)
24. Sohn TA, Yeo CJ, Cameron JL, et al.: Resected adenocarcinoma of the pancreas-616 patients: Results, outcomes, and prognostic indicators. J Gastrointest Surg 2000;4:567-579.
25. Spitz FR, Abbruzzese JL, Lee JE, et al.: Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 1997;15:928-937. (Pubitemid 27106274)
26. Cheng TY, Sheth K, White RR, et al.: Effect of neoadjuvant chemoradiation on operative mortality and morbidity for pancreaticoduodenectomy. Ann Surg Oncol 2006;13:66-74. (Pubitemid 43117647)
27. Vento P, Mustonen H, Joensuu T, et al.: Impact of preoperative chemoradiotherapy on survival in patients with resectable pancreatic cancer. World J Gastroenterol 2007;13:2945-2951. (Pubitemid 47033753)
28. White RR, Hurwitz HI, Morse MA, et al.: Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas. Ann Surg Oncol 2001;8:758-765. (Pubitemid 34003323)
29. White R, Winston C, Gonen M, et al.: Current utility of staging laparoscopy for pancreatic and peripancreatic neoplasms. J Am Coll Surg 2008;206:445-450. (Pubitemid 351282524)
30. Tamm EP, Loyer EM, Faria S, et al.: Staging of pancreatic cancer with multidetector CT in the setting of preoperative chemoradiation therapy. Abdom Imaging 2006;31:568-574. (Pubitemid 46360846)
31. Valls C, Andia E, Sanchez A, et al.: Dual-phase helical CT of pancreatic adenocarcinoma: Assessment of resectability before surgery. AJR Am J Roentgenol 2002;178:821-826. (Pubitemid 34250214)
32. Wolff RA, Evans DB, Gravel DM, et al.: Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma. Clin Cancer Res 2001;7: 2246-2253. (Pubitemid 32751621)
33. Guarner L, Navalpotro B, Molero X, et al.: Management of painful chronic pancreatitis with single-dose radiotherapy. Am J Gastroenterol 2009;104:349-355. Epub 2009 Jan 27.